Menu
Currency
GWAS Study

A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.

Moltke I, Grarup N, Jørgensen ME et al.

25043022 PubMed ID
GWAS Study Type
3385 Participants
88 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MI
Moltke I
GN
Grarup N
JM
Jørgensen ME
BP
Bjerregaard P
TJ
Treebak JT
FM
Fumagalli M
KT
Korneliussen TS
AM
Andersen MA
NT
Nielsen TS
KN
Krarup NT
GA
Gjesing AP
ZJ
Zierath JR
LA
Linneberg A
WX
Wu X
SG
Sun G
JX
Jin X
AJ
Al-Aama J
WJ
Wang J
BK
Borch-Johnsen K
PO
Pedersen O
NR
Nielsen R
AA
Albrechtsen A
HT
Hansen T
Chapter II

Abstract

Summary of the research findings

The Greenlandic population, a small and historically isolated founder population comprising about 57,000 inhabitants, has experienced a dramatic increase in type 2 diabetes (T2D) prevalence during the past 25 years. Motivated by this, we performed association mapping of T2D-related quantitative traits in up to 2,575 Greenlandic individuals without known diabetes. Using array-based genotyping and exome sequencing, we discovered a nonsense p.Arg684Ter variant (in which arginine is replaced by a termination codon) in the gene TBC1D4 with an allele frequency of 17%. Here we show that homozygous carriers of this variant have markedly higher concentrations of plasma glucose (β = 3.8 mmol l(-1), P = 2.5 × 10(-35)) and serum insulin (β = 165 pmol l(-1), P = 1.5 × 10(-20)) 2 hours after an oral glucose load compared with individuals with other genotypes (both non-carriers and heterozygous carriers). Furthermore, homozygous carriers have marginally lower concentrations of fasting plasma glucose (β = -0.18 mmol l(-1), P = 1.1 × 10(-6)) and fasting serum insulin (β = -8.3 pmol l(-1), P = 0.0014), and their T2D risk is markedly increased (odds ratio (OR) = 10.3, P = 1.6 × 10(-24)). Heterozygous carriers have a moderately higher plasma glucose concentration 2 hours after an oral glucose load than non-carriers (β = 0.43 mmol l(-1), P = 5.3 × 10(-5)). Analyses of skeletal muscle biopsies showed lower messenger RNA and protein levels of the long isoform of TBC1D4, and lower muscle protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles. These findings are concomitant with a severely decreased insulin-stimulated glucose uptake in muscle, leading to postprandial hyperglycaemia, impaired glucose tolerance and T2D. The observed effect sizes are several times larger than any previous findings in large-scale genome-wide association studies of these traits and constitute further proof of the value of conducting genetic association studies outside the traditional setting of large homogeneous populations.

2,540 Greenlandic ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

3385
Total Participants
GWAS
Study Type
Yes
Replicated
845 Greenlandic ancestry individuals
Replication Participants
Greenland
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.